You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Moexipril hydrochloride - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for moexipril hydrochloride and what is the scope of freedom to operate?

Moexipril hydrochloride is the generic ingredient in two branded drugs marketed by Apotex Inc, Chartwell Rx, Glenmark Generics, Teva, and Ucb Inc, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for moexipril hydrochloride. Two suppliers are listed for this compound.

Summary for moexipril hydrochloride
Recent Clinical Trials for moexipril hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of NebraskaPhase 4
Teva Pharmaceuticals USAPhase 1
UCB PharmaPhase 2

See all moexipril hydrochloride clinical trials

Pharmacology for moexipril hydrochloride
Anatomical Therapeutic Chemical (ATC) Classes for moexipril hydrochloride

US Patents and Regulatory Information for moexipril hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ucb Inc UNIVASC moexipril hydrochloride TABLET;ORAL 020312-001 Apr 19, 1995 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Apotex Inc MOEXIPRIL HYDROCHLORIDE moexipril hydrochloride TABLET;ORAL 078454-001 Jun 2, 2008 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Teva MOEXIPRIL HYDROCHLORIDE moexipril hydrochloride TABLET;ORAL 076204-002 May 8, 2003 AB RX No Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Glenmark Generics MOEXIPRIL HYDROCHLORIDE moexipril hydrochloride TABLET;ORAL 090416-002 Mar 30, 2010 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Ucb Inc UNIVASC moexipril hydrochloride TABLET;ORAL 020312-002 Apr 19, 1995 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Chartwell Rx MOEXIPRIL HYDROCHLORIDE moexipril hydrochloride TABLET;ORAL 077536-002 Nov 30, 2006 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for moexipril hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ucb Inc UNIVASC moexipril hydrochloride TABLET;ORAL 020312-001 Apr 19, 1995 ⤷  Try a Trial ⤷  Try a Trial
Ucb Inc UNIVASC moexipril hydrochloride TABLET;ORAL 020312-001 Apr 19, 1995 ⤷  Try a Trial ⤷  Try a Trial
Ucb Inc UNIVASC moexipril hydrochloride TABLET;ORAL 020312-002 Apr 19, 1995 ⤷  Try a Trial ⤷  Try a Trial
Ucb Inc UNIVASC moexipril hydrochloride TABLET;ORAL 020312-002 Apr 19, 1995 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.